logo
科言猫学术研究的AI总结
language
手机端手机端
  • Phone Feature微信小程序
简体中文简体中文
notice消息通知
博客博客
arrow
G

Guang-Yu Liu

Key Laboratory of Breast Cancer in Shanghai
H指数:30
被引数:3,341

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Intensive chemotherapy versus standard chemotherapy among patients with high risk, operable, triple negative breast cancer based on integrated mRNA-lncRNA signature (BCTOP-T-A01): randomised, multicentre, phase 3 trial

基于整合mrna-lncrna签名 (BCTOP-T-A01) 的高风险，可手术，三阴性乳腺癌患者的强化化疗与标准化疗: 随机，多中心，3期试验

BMJ-BRITISH MEDICAL JOURNAL
IF42.7
2024-10-230
PRE
He, Min; Jiang, Yi-Zhou; Gong, Yue; Fan, Lei; Liu, Xi-Yu; Liu, Yin; Tang, Li-Chen; Mo, Miao; Hou, Yi-Feng; Di, Gen-Hong; Liu, Guang-Yu; Yu, Ke-Da; Wu, Jiong; Yan, Xia; Zeng, Xiao-Hua; Fu, De-Yuan; Song, Chuan-Gui; Zhuang, Zhi-Gang; Wu, Ke-Jin; Wang, Jie; Wang, Zhong-Hua; Shao, Zhi-Ming
Neoadjuvant anthracycline followed by toripalimab combined with nab-paclitaxel in patients with early triple-negative breast cancer (NeoTENNIS): a single-arm, phase II study

早期三阴性乳腺癌患者 (新网球) 的新辅助蒽环类药物联合toripalimab和nab紫杉醇: 一项单臂II期研究

ECLINICALMEDICINE
IF10
2024-08-012
OAAI
He, Min; Hao, Shuang; Ma, LinXiaoxi; Xiu, BingQiu; Yang, BenLong; Wang, ZeHao; Xue, JingYan; Chi, YaYun; Xiong, Min; Chen, Jiajian; Huang, XiaoYan; Liu, XiYu; Wu, SongYang; Xiao, Qin; Huang, Yan; Shui, RuoHong; Cao, AYong; Li, JunJie; Di, GenHong; Yang, WenTao; Hu, Xin; Liu, GuangYu; Yu, KeDa; Jiang, YiZhou; Wang, ZhongHua; Shao, ZhiMing; Wu, Jiong

研究方向

暂未获取到该数据
J
Jiong Wu
H 指数:65论文数:565被引数:1.3万
K
Ke‐Da Yu
H 指数:50论文数:315被引数:1.0万
G
Gen‐Hong Di
H 指数:42论文数:224被引数:5,324
邵
邵志敏
H 指数:46论文数:367被引数:1.3万
J
Junjie Li
H 指数:14论文数:51被引数:1,135
邵
邵志敏
H 指数:62论文数:397被引数:1.4万
B
Benlong Yang
H 指数:15论文数:98被引数:728
Y
Yi‐Zhou Jiang
H 指数:51论文数:407被引数:9,756
Z
Zhen‐Zhou Shen
H 指数:34论文数:96被引数:3,809
J
Jiong Wu
H 指数:8论文数:87被引数:2,279